MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status - Concepedia

Concepedia

Publication | Open Access

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status

DOI Full Paper Access

39

Citations

39

References

1995

Year

GWH Stamp, Saliha Afzal, CP McFarlane, John Trowsdale

British Journal of Cancer

Ovarian Carcinoma IrrespectiveMedicinePathologyGynecologyTp53 Mutation StatusCancer BiologyTumor SuppressorCancer GeneticsOncologyTumor BiologyMdm2 OverexpressionOvarian Cancer

References

	Year	Citations

Page 1